Cañeque-Rufo Héctor, Fontán-Baselga Teresa, Galán-Llario Milagros, Zuccaro Agata, Sánchez-Alonso María Gracia, Gramage Esther, Ramos-Álvarez María Del Pilar, Herradón Gonzalo
Department of Health and Pharmaceutical Sciences, School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain; Department of Chemistry and Biochemistry, School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain.
Department of Health and Pharmaceutical Sciences, School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain.
Neurobiol Dis. 2025 Feb;205:106776. doi: 10.1016/j.nbd.2024.106776. Epub 2024 Dec 23.
Obesity and metabolic disorders, such as metabolic syndrome (MetS) facilitate the development of neurodegenerative diseases and cognitive decline. Persistent neuroinflammation plays an important role in this process. Pleiotrophin (PTN) is a cytokine that regulates energy metabolism and high-fat diet (HFD)-induced neuroinflammation, suggesting that PTN could play an important role in the connection between obesity and brain alterations, including cognitive decline. To test this hypothesis, we used an HFD-induced obesity model in Ptn genetically deficient mice (Ptn). First, we confirmed that Ptn deletion prevents HFD-induced obesity. Our findings demonstrate that feeding wild-type (Ptn) mice with HFD for 6 months results in short- and long-term memory loss in the novel object recognition task. Surprisingly, we did not observe any sign of cognitive impairment in Ptn mice fed with HFD. In addition, we observed that HFD induced microglial responses, astrocyte depletion, and perineuronal nets (PNNs) alterations in Ptn mice, while these effects of HFD were mostly prevented in Ptn mice. These results show a crucial role of PTN in metabolic responses and brain alterations induced by HFD and suggest the PTN signalling pathway as a promising therapeutic target for brain disorders associated with MetS.
肥胖和代谢紊乱,如代谢综合征(MetS),会促进神经退行性疾病的发展和认知能力下降。持续性神经炎症在这一过程中起重要作用。多效生长因子(PTN)是一种调节能量代谢和高脂饮食(HFD)诱导的神经炎症的细胞因子,这表明PTN可能在肥胖与包括认知能力下降在内的大脑改变之间的联系中发挥重要作用。为了验证这一假设,我们在Ptn基因缺陷小鼠(Ptn-/-)中使用了高脂饮食诱导的肥胖模型。首先,我们证实了Ptn基因缺失可预防高脂饮食诱导的肥胖。我们的研究结果表明,给野生型(Ptn+/+)小鼠喂食高脂饮食6个月会导致其在新物体识别任务中出现短期和长期记忆丧失。令人惊讶的是,我们在喂食高脂饮食的Ptn-/-小鼠中未观察到任何认知障碍迹象。此外,我们观察到高脂饮食会诱导Ptn+/+小鼠出现小胶质细胞反应、星形胶质细胞耗竭和神经元周围网(PNNs)改变,而在Ptn-/-小鼠中,高脂饮食的这些影响大多得到了预防。这些结果表明PTN在高脂饮食诱导的代谢反应和大脑改变中起关键作用,并表明PTN信号通路是与代谢综合征相关的脑部疾病的一个有前景的治疗靶点。